Oxidative stress in viral hepatitis and AIDS. (Q35879726)

10 August 2017

1 reference

title

Oxidative stress in viral hepatitis and AIDS. (English)

1 reference

10 August 2017

1 reference

William E Stehbens

1

1 reference

PubMed ID

15351235

10 August 2017

language of work or name

1 reference

1 October 2004

1 reference

Experimental and Molecular Pathology

10 August 2017

1 reference

10 August 2017

77

1 reference

10 August 2017

2

1 reference

10 August 2017

121-132

1 reference

Caspase activation correlates with the degree of inflammatory liver injury in chronic hepatitis C virus infection

10 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2004.04.007

HIV-1 infection in women is associated with severe nutritional deficiencies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2004.04.007

High Risk of HIV-Related Mortality Is Associated With Selenium Deficiency

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2004.04.007

Nutritionally induced oxidative stress: effect on viral disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2004.04.007

Antioxidants and viral infections: host immune response and viral pathogenicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2004.04.007

Zinc potentiates the antiviral action of human IFN-alpha tenfold

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2004.04.007

Natural killer cells in antiviral defense: function and regulation by innate cytokines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2004.04.007

Lipid-lowering drugs (statins), cholesterol, and coenzyme Q10. The Baycol case--a modern Pandora's box.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2004.04.007

Antioxidant status and glutathione metabolism in peripheral blood mononuclear cells from patients with chronic hepatitis C

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2004.04.007

Systemic glutathione deficiency in symptom-free HIV-seropositive individuals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2004.04.007

Oxidative stress as a mediator of apoptosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2004.04.007

Zinc supplementation reconstitutes the production of interferon-alpha by leukocytes from elderly persons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2004.04.007

Mortality risk in selenium-deficient HIV-positive children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2004.04.007

Hepatitis B virus immunopathogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2004.04.007

The diversity of coenzyme Q function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2004.04.007

Treatment of chronic hepatitis C

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2004.04.007

The amount of thiolic antioxidant ingestion needed to improve several immune functions is higher in aged than in adult mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2004.04.007

Association between reactive oxygen species and disease activity in chronic hepatitis C

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2004.04.007

The biological basis for clinical use of interferon

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2004.04.007

Biochemical, physiological and medical aspects of ubiquinone function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2004.04.007

AIDS, zinc deficiency, and thymic hormone failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2004.04.007

Antioxidant status and lipid peroxidation in patients infected with HIV.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2004.04.007

Clastogenic factors in plasma of HIV-1 infected patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2004.04.007

Inhibition of interferon-mediated antiviral responses by influenza A viruses and other negative-strand RNA viruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2004.04.007

A preliminary trial of beta-carotene in subjects infected with the human immunodeficiency virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2004.04.007

Increased therapeutic efficacy of zidovudine in combination with vitamin E.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2004.04.007

The interferon antiviral response: from viral invasion to evasion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2004.04.007

Extensive oxidative DNA damage in hepatocytes of transgenic mice with chronic active hepatitis destined to develop hepatocellular carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2004.04.007

Antioxidants and human disease: a general introduction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2004.04.007

Suppression of human immunodeficiency virus replication by ascorbate in chronically and acutely infected cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2004.04.007

Protection of chicks against E. coli infection by dietary supplementation with vitamin E

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2004.04.007

Therapy for acute hepatitis C

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2004.04.007

p53 gene mutation and integrated hepatitis B viral DNA sequences in human liver cancer cell lines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2004.04.007

Treatment of acute hepatitis C with interferon alfa-2b

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2004.04.007

Suppression of human immunodeficiency virus expression in chronically infected monocytic cells by glutathione, glutathione ester, and N-acetylcysteine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2004.04.007

Superoxide dismutase in patients with chronic hepatitis C virus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2004.04.007

Hepatitis C in clinical practice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2004.04.007

Type i interferons potently enhance humoral immunity and can promote isotype switching by stimulating dendritic cells in vivo.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2004.04.007

Inflammation, oxidative DNA damage, and carcinogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2004.04.007

Relationship of plasma malondialdehyde, vitamin E and antioxidant micronutrients to human immunodeficiency virus-1 seropositivity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2004.04.007

Influence of vitamins E and B6 on immune response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2004.04.007

Isoniazid liver injury: clinical spectrum, pathology, and probable pathogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2004.04.007

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2004.04.007

Therapeutic application of zinc in human immunodeficiency virus against opportunistic infections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2004.04.007

Preliminary study of combination therapy with interferon-alpha and zinc in chronic hepatitis C patients with genotype 1b

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2004.04.007

Esophageal carcinogenesis in the rat: zinc deficiency, DNA methylation and alkyltransferase activity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2004.04.007

Chronic infections and inflammatory processes as cancer risk factors: possible role of nitric oxide in carcinogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2004.04.007

Reactive oxygen species and nitric oxide in viral diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2004.04.007

Hepatocarcinogenicity of the woodchuck hepatitis virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2004.04.007

Zinc: the biology and therapeutics of an ion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2004.04.007

Effects of zinc deficiency on Th1 and Th2 cytokine shifts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2004.04.007

The importance of selenium to human health

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2004.04.007

The pharmacological role of zinc: evidence from clinical studies on animals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2004.04.007

Cytokine-stimulated human immunodeficiency virus replication is inhibited by N-acetyl-L-cysteine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2004.04.007

ABC of diseases of liver, pancreas, and biliary system: Acute hepatitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2004.04.007

Oxidative stress during viral infection: a review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2004.04.007

Vitamin C status in patients with acute pancreatitis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2004.04.007

7 January 2021

Viruses and interferons

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2004.04.007

Zinc and immune function: the biological basis of altered resistance to infection.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2004.04.007

Significance of plasma glutathione determination in patients with alcoholic and non-alcoholic liver disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2004.04.007

Effect of zinc ions on the synthesis of herpes simplex virus DNA in infected BSC-1 cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2004.04.007

Immunologic Responses of Mice Fed Diets Supplemented with Selenite Selenium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2004.04.007

Zinc-controlled Th1/Th2 switch significantly determines development of diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2004.04.007

Glutathione deficiency and human immunodeficiency virus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2004.04.007

Coronary heart disease, hypercholesterolemia, and atherosclerosis. II. Misrepresented data

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2004.04.007

Oxidative stress, toxic hepatitis, and antioxidants with particular emphasis on zinc

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2004.04.007

Zinc supplementation enhances the response to interferon therapy in patients with chronic hepatitis C.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2004.04.007

Determinants of viral clearance and persistence during acute hepatitis C virus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2004.04.007

The hepatitis B virus and the host response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2004.04.007

The biochemical basis of zinc physiology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2004.04.007

Reactivation of hepatitis B virus in a previously immune patient with human immunodeficiency virus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2004.04.007

Fulminant Hepatitis Associated with Hepatitis A Virus Superinfection in Patients with Chronic Hepatitis C

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2004.04.007

Role of cytochrome b5 reductase on the antioxidant function of coenzyme Q in the plasma membrane

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2004.04.007

The immunobiology of zinc

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2004.04.007

Delivery of the Cu/Zn-superoxide dismutase gene with adenovirus reduces early alcohol-induced liver injury in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2004.04.007

Plasma ratio of ubiquinol and ubiquinone as a marker of oxidative stress

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2004.04.007

Plasma antioxidant vitamins, chronic hepatitis B virus infection and urinary aflatoxin B1-DNA adducts in healthy males

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2004.04.007

Effect of zinc on the immune status of zinc-depleted AIDS related complex patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2004.04.007

Enhanced interferon response to murine leukemia virus by ascorbic acid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2004.04.007

10.1016/J.YEXMP.2004.04.007

7 January 2021

Identifiers

DOI

1 reference

10 August 2017

1 reference

PubMed ID

15351235